Dipeptides Enhance Recombinant Protein Titer in Serum-Free Media
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for methods to improve recombinant protein production in completely defined media, as protein hydrolysates can introduce heterogeneity and serum-free cell cultures are sensitive to nutritional deficiencies, leading to apoptosis and reduced protein quality and titer.
Innovation Solution
The method involves culturing CHO cells in a serum-free medium during the growth phase and a serum-free defined production phase, supplemented with specific dipeptides such as Tyr-His, Tyr-Lys, Tyr-Ala, Tyr-Val, His-Gly, and Ala-His, which improves protein titer and cell viability, and can also include Thr-Phe, His-Glu, Glu-His, His-Ser, and His-Gln to enhance viable cell density and metabolic stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If serum-free defined medium is used for cell culture, then media heterogeneity is eliminated and regulatory compliance is improved, but cell sensitivity to nutritional deficiencies increases leading to apoptosis and reduced protein production
Solution Approach 1:
The invention changes the chemical composition parameters of the serum-free medium by adding specific dipeptides (Tyr-His, Tyr-Lys, Tyr-Ala, Tyr-Val, His-Gly, and Ala-His) to address nutritional deficiencies. This parameter modification resolves the contradiction by maintaining media definition while improving cell viability and protein production.
Solution Approach 2:
The dipeptides act as intermediary substances that mediate between the defined medium and cell nutritional requirements. These dipeptides serve as building blocks that cells can utilize directly, bridging the gap between media simplicity and cellular nutritional needs, thereby improving protein production without compromising media definition.
2Stability of the object's composition
If serum-free defined medium is used, then media homogeneity and regulatory compliance are improved, but cell viability and culture duration are reduced due to nutritional deficiencies
Solution Approach 1:
The invention modifies the chemical composition parameters of the medium by incorporating specific dipeptides that provide essential nutritional components. This parameter change maintains media homogeneity while extending culture duration by preventing apoptosis and supporting sustained cell viability.
Solution Approach 2:
The dipeptides are added to the medium in advance to prevent nutritional deficiencies before they cause cell damage. This preliminary nutritional supplementation ensures cells remain viable for extended periods throughout the culture process.
3Device complexity
If serum-free defined medium is used, then process simplicity and regulatory compliance are improved, but recombinant protein titer is reduced due to apoptosis
Solution Approach 1:
The invention changes the compositional parameters of the medium by adding specific dipeptides, which prevents apoptosis and improves protein titer. This simple compositional modification resolves the contradiction between process simplicity and protein production quantity.
Solution Approach 2:
The dipeptides serve as intermediary nutrients that enable high protein titers in simple defined media. They mediate between the simplicity of the medium and the cellular requirements for high-level protein production, preventing cell death and maximizing yield.
4Productivity
If serum supplementation is used, then cell viability and protein production are improved, but media heterogeneity and regulatory concerns increase
Solution Approach 1:
The invention extracts and isolates the beneficial components (specific dipeptides) from complex serum formulations. By taking out only the essential dipeptide building blocks needed for cell growth and protein production, the invention eliminates serum heterogeneity while preserving the productivity benefits.
Solution Approach 2:
The invention changes the media composition by replacing complex serum with a defined mixture of specific dipeptides. This parameter change maintains the productivity benefits of serum supplementation while achieving the media definition and regulatory compliance required for commercial production.
Data Source
AI summary
The present invention relates to the culture of animal cells in serum-free culture medium. The present invention provides particular dipeptides that can improve recombinant protein production and cell viability in such cultures, especially in the absence of peptones.